Giovanni Camussi is an expert in Nephrology at University of Turin (Italy). Giovanni Camussi has authored 695 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 2,325 (community average: 125). How the SLR is computed.

LeadR Profile

Giovanni Camussi University of Turin Italy
2 325 ScienceLeadR Reputation 2325
Network Map

Nephrology

Subspecialties: Biochemistry - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1976 - 2026

Source: PubMed

University of Turin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 695

Citations

Citations: 53 728 1st author: 98 Last author: 293 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
MSC-Derived Extracellular Vesicles Mitigate Ischemia-Induced Energetic Dysfunction During Ex Situ Perfusion of Rat Livers.
PMID 42510574 — cells, extracellular vesicles, stress, physiological, adenosine, liver, reperfusion injury, flavin mononucleotide, ischemia
Antioxidants (Basel)20260
Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.
PMID 42168057 — cells, proteinuria, extracellular vesicles, lipoproteins, blood component removal, kidney, nephrotic syndrome, therapeutics, mutation, plasma
J Clin Lipidol20260
Good Manufacturing Practice-Derived Human Liver Stem Cell Extracellular Vesicles Attenuate Liver Fibrosis In Vivo.
PMID 42041529 — cells, extracellular vesicles, microscopy, electron, scanning transmission, fibrosis, stem cells, liver, thioacetamide, therapeutics
Cells20260
Orange-Derived Extracellular Vesicles: Characterization and Therapeutic Applications in Normal and Diabetic Wound Healing in In Vivo Models.
PMID 41677611 — diabetes mellitus, cells, extracellular vesicles, therapeutics
Cells20260
Clinical Validation of α-Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study.
PMID 41603154 — extracellular vesicles, longitudinal studies, parkinson disease, biomarkers, diagnosis, nervous system diseases, synucleins
Eur J Neurol20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 2
Phase 4 1

By status:

Completed 2
Recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map